SS

Sriram Sridevi

Director Director DIN 06733087
DIN 06733087 First appointment Dec 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2013
Shareholding value Locked Premium profile

About Sriram Sridevi

Data last updated:

Sriram Sridevi has 12 years in corporate governance. Formerly with 1 company, such as Arkas Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06733087
Primary Designation Director
First Appointment 12 Dec 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Arkas Pharma Private Limited U24232TG2013PTC091634
Director12 Dec 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arkas Pharma Private Limited
Premium access

Shareholding and investment profile for Sriram Sridevi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriram Sridevi

Sriram Sridevi has 12 years in corporate governance. Formerly with 1 company, such as Arkas Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sriram Sridevi is associated with 0 companies as a director.

Sriram Sridevi has expertise in General Business.

Sriram Sridevi has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available